
These are Longleaf Partners Global Fund's own holdings, not the firm's. Percentages are of the stock positions in its latest filing — the fund's cash and bonds are not included. This fund takes Southeastern's patient value approach beyond the United States, hunting across the world for strong businesses run by capable, shareholder-aligned managers bought at a discount to what they are appraised to be worth. Where the firm's flagship funds stick largely to American stocks, this one casts a wider net: it can hold companies anywhere, including the United States, though a good share of the portfolio is typically parked outside the country. Hawkins's watchwords for every pick — business, people, price — apply the same way abroad as at home, and the fund stays true to the house style of running a concentrated book of roughly two dozen names held for years. The fund opened on December 27, 2012, nearly four decades after Hawkins founded Southeastern in Memphis in the wake of the 1973-74 market crash, and about a quarter-century after the firm launched its original Longleaf Partners funds in 1987. It grew out of the firm's earlier international work: Southeastern had run a separately managed global strategy since 2000 and an International Fund since 1998 that focused only on non-U.S. businesses, a vehicle that was later folded into this broader global mandate. The fund is managed today by Hawkins alongside Ross Glotzbach, who joined the firm in 2004 and rose to become its chief executive and head of research.
Longleaf Partners Global Fund exited Bio-Rad Laboratories, Walt Disney, Louisiana-Pacific, Potlatchdeltic, and Louis Hachette Group. It sharply increased its Rayonier stake and substantially added to Mattel, IDP Education, and Fortune Brands Innovations. The fund substantially trimmed FedEx and Menicon, while moderately reducing CNX Resources, Regeneron Pharmaceuticals, Magnum Ice Cream, Gruma, Koninklijke Philips, Glanbia, Kraft Heinz, and Medley.
Full March 2026 recap →Stock Value
$624.48M
Positions
21
Top Position
RYN 8.5%
Top 10
64%